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Abstract
Coxiella burnetii infection (Q fever) is a widespread zoonosis with low endemicity in Switzerland, therefore no mandatory public report was
required. A cluster of initially ten human cases of acute Q fever infections characterized by prolonged fever, asthenia and mild hepatitis
occurred in 2012 in the terraced vineyard of Lavaux. Epidemiological investigations based on patients’ interviews and veterinary
investigations included environmental sampling as well as Coxiella-specific serological assay and molecular examinations (real-time PCR in
vaginal secretions) of suspected sheep. These investigations demonstrated that 43% of sheep carried the bacteria whereas 30% exhibited
anti-Coxiella antibodies. Mitigation measures, including limiting human contacts with the flock, hygiene measures, flock vaccination and a
public official alert, have permitted the detection of four additional human cases and the avoidance of a much larger outbreak. Since
November 2012, mandatory reporting of Q fever to Swiss public health authorities has been reintroduced. A close follow up of human
cases will be necessary to identify chronic Q fever.
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Introduction
Q fever is an infection caused by Coxiella burnetii, a natu-
rally intracellular Gram-negative bacterium. ‘Q’ stands for
Query and this name was first used in 1935 during an outbreak
of febrile illness among abattoir workers in Brisbane,
Queensland (Australia) when the causative agent was still
unknown [1, 2].
Common reservoirs of this worldwide zoonotic disease are
wild and domestic animals, especially sheep, goats, cattle and
occasionally pets. Infected animals are often asymptomatic, but
abortions and other reproductive disorders can manifest.
Shedding occurs in urine, milk, faeces, and in particular through
birth products from infected animals [2–4].
As spore-like forms of C. burnetii can survive for months in
the environment and the bacteria have been documented in
dust samples [5,6], infections do not necessarily require direct
contact with diseased animals. Inhalation of aerosolized
particles is the primary transmission route [7,8]. Infections
through direct skin contact, ingestion of contaminated raw
milk and goat cheese have also been described [2]. Rare
human-to-human transmissions following contact with infected
placenta, human milk exposure and via blood transfusions have
also been documented [2,9–11].
After an incubation period of around 20 days (range 9–
39 days), non-immune exposed persons develop a primary
infection. Acute infection remains asymptomatic in around
60% of cases [3,12–14]. For the remaining 40% of cases, acute
Q fever usually manifests as self-limited, flu-like illness,
interstitial pneumonia or acute hepatitis [15]. Spontaneous
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abortion or premature delivery can occur in pregnant women
[15,16]. Only 5% of the symptomatic persons will require
hospitalization [13].
In 1–5% of all infections, Q fever progresses into a chronic
form, whose localization (e.g. endocarditis, vascular infection,
granulomatous hepatitis, osteomyelitis) depends on host risk
factors and C. burnetii isolate groups [3,15,17,18].
Recently the Netherlands experienced the largest outbreak
ever recorded, with more than 4000 human cases by 2011
[19,20]. In Switzerland, a European country of about
8 000 000 inhabitants, the incidence of Q fever is about 0.15
cases per 100 000 inhabitants, corresponding to around 10–12
infections per year (http://www.bag.admin.ch/dokumentation/
publikationen). Given this low incidence, reports of human
cases to public health authorities were no longer mandatory
after 1999, so its epidemiology is now largely unknown (http://
www.bag.admin.ch/dokumentation/publikationen). Outbreaks
were rarely reported, and only one large Swiss outbreak has
been documented in the ‘Val de Bagnes’ in 1983 [21].
In Switzerland, abortions of cloven-hoofed animals have to
be reported to the veterinary authorities. Between 2002 and
2011, 583 abortions due to C. burnetii infections were reported,
82% of them in cattle, 12% in goats and 6% in sheep (http://
www.bvet.admin.ch/themen/03605/index.html?lang=fr). In the
last 5 years, around 60–80 animal infections occurred each year
(http://www.bvet.admin.ch/themen/03605/index.html?lang=fr).
Screening of the milk products from Swiss animals has shown
that C. burnetii contamination occurred in <5% of cattle
products, and never in sheep or goat samples [22].
Because of the asymptomatic nature of most human
infections and the rarity of the disease in Switzerland, Q fever
is poorly known among general practitioners, and only rarely
considered in the differential diagnosis of flu-like illnesses. We
report the results of an outbreak investigation of 14 cases in
the terraced vineyards of Lavaux, Canton of Vaud, Switzerland,
and describe related environmental and veterinary investiga-
tions.
Methods
Epidemiological description
Between February and May 2012 an unusually high number of
hospitalized cases was observed in three different Swiss
hospitals, located in Vevey (n = 1) and in Lausanne (n = 2).
The initial cluster of ten cases was reported to the public
health authorities. Considering the rarity of this disease, and the
lack of knowledge about this infection among general practi-
tioners, we suspected that these few cases indicated a much
larger outbreak and a larger investigation was initiated
allowing the identification of 4 additional cases. The patients
presented acute and prolonged febrile illness up to 2 weeks
associated with asthenia and hepatitis. Table 1 summarizes the
clinical presentation of the 14 cases and Table 2 shows the rate
of the majority of symptoms and signs documented for these 14
cases. These cases included two episodes of biopsy-proven
granulomatous hepatitis (patients 1 and 3) and one vertebral
osteomyelitis (patient 6). Acute Q fever diagnoses were based
on positive serologies, defined as a phase II IgM titre ≥40 IU/L
and phase II IgG titre ≥40 IU/L (immunofluorescence assay)
[13]. Briefly, sera were screened by indirect immunofluores-
cence assay at a starting dilution of 1/20 using Coxiella burnetii
phase I and II antigens (strain Nine Miles, kindly provided by Dr
W. Burgdorfer, Rocky Mountain Laboratories, Hamilton, USA)
[23]. Fluorescein isothiocyanate goat anti-human specific IgG
and IgM conjugates (BioMerieux, Marcy-l’Etoile, France) were
used for detection. Serology was often performed after more
than 10 days of intra-hospital investigations, secondary to
infectious disease consultation. In seven cases (patients 5, 7, 8,
11,12,13,14), for which initial serology was negative, serocon-
version was documented 14 days later. Only in one case
(patient 12), could C. burnetii DNA be detected by real-time
PCR in serum [24]. The PCR was also positive in one of the two
liver biopsies that were performed (patient 1) and in another
case in a bone biopsy (patient 6). Two cases had predisposing
risk factors for chronic Q fever (patients 1 and 3).
Epidemiological investigation and public health measures
Investigations initially included patient interviews, review of
medical records and evaluation of risk factors for exposure to
Q fever (working and living places, environmental exposure,
animal contact and food habits), which identified a sheep farm
as a possible source of the outbreak (coined hereafter as the
‘index farm’).
Based on this information, a veterinary investigation was
launched in June 2012. At that time, all the sheep had already
been transferred to Alpine pastures near the lake of l’Hongrin,
in the Canton of Vaud. On the farm, most manure had been
removed and the floor had been flushed with water. As a first
step, on-farm sampling of dust and manure as well as an
interview with the farmer were carried out. In total, five dust
samples were taken from horizontal surfaces such as feed
troughs (n = 2) and windowsills (n = 3), as described else-
where [25]. Furthermore, six manure samples were collected
in sterile vials from different locations on the ground. All
samples were frozen at 20°C until further processing. In July
2012, 52 sheep, part of the flock suspected as the source of
the outbreak and now located in the Alps, were randomly
sampled for serology and real-time PCR examinations of
vaginal swabs. Sera were tested for the presence of antibodies
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TABLE 1. Patient descriptions, including predisposing and exposure risk factors, clinical presentation and evolution
No.
Age (years)
at diagnosis;
gender
First symptoms
(month/year)
Clinical
presentation
Diagnosis of Coxiella
burnetii infection
Predisposing
conditions
Anamnestic
exposure risk
factors
Treatment and evolution
including clinical
investigations
1 62; M 04/2011a Flu-like symptoms
Granulomatous
hepatitis
Positive serology
and PCR in liver
biopsy (granuloma)
TNF-a inhibitors
for Bechterew
disease
Regular visits to
friends in the farm
Doxycycline 100 mg twice
daily for 21 days
TTE normal at screening
and at 6 months; TA-CT
normal at 1 year
Recovery
2 66; M 06/2011b Flu-like symptoms
Hepatitis
Positive serology None Live in the region; eat
unpasteurized goat
cheese and local
market vegetables
Doxycycline 100 mg twice
daily for 14 days
TTE normal at screening
and at 4 months; TEE
normal at 4 months; bone
scintigraphy normal at
4 months
Recovery after 1 year
3 59; M 02/2012b Flu-like symptoms
Granulomatous
hepatitis
Positive serology
Negative PCR in
liver biopsy
Aortic bicuspidia
and aneurysm
Regular visits to friends
in the farm
Doxycycline plus hydroxyl
chloroquine (skin rash);
switch to doxycycline plus
rifampin
TTE showing aortic
bicuspidia and aneurysm of
ascending aorta at screening
Resolution of hepatitis
4 64; F 04/2012b Flu-like symptoms
Hepatitis
Positive serology None Live in the region; eat
local market vegetables
Doxycycline 100 mg twice
daily for 14 days
TTE normal at screening
Recovery after 3 months
5 44; M 04/2012b Flu-like symptoms
Hepatitis
Documented
seroconversion
None Live in the region; eat
local market vegetables
Doxycycline 100 mg twice
daily for 14 days
TTE normal at screening
Recovery after 3 months
6 57; M 04/2012 Spondylodiscitis
Hepatitis
Positive serology
and PCR on
vertebral biopsy
Vertebral trauma
2 months earlier
Regular visits to friends
in the farm; eat local
market vegetables
Doxycycline plus hydroxyl
chloroquine (cutaneous
lupus) switch to ciprofloxacin
plus rifampin
TEE and TA-CT normal at
screening
Resolution of hepatitis
Persistence of vertebral
inflammation on vertebral
MRI at 3 months
7 44; M 05/2012 Flu-like symptoms
Hepatitis
Documented
seroconversion
None Work in the region Doxycycline 100 mg twice
daily for 14 days
TTE normal at screening
Recovery after 14 days
8 73; F 05/2012 Flu-like symptoms
Hepatitis
Interstitial
pneumonia
Documented
seroconversion
Negative PCR in
lung secretions
Chronic renal
impairment;
sequels following
breast radiotherapy
for cancer
Regular walk in the
region; eat local
market vegetables
Doxycycline 100 mg twice
daily for 14 days
Recovery after 3 months
9 44; F 05/2012 Flu-like symptoms Positive serology None Live in the farm; have
direct contact with
goats; eat farm
vegetables
Doxycycline 100 mg twice
daily for 14 days
TEE normal at screening
Recurrence of symptoms
after 3 months and new
elevation of phase
2 antibodies; TA-CT normal
Recovery after 14 days of
ciprofloxacine treatment
10 51; M 05/2012 Flu-like symptoms Positive serology None Live in the farm; have
direct contact with
goats; eat farm
vegetables
No treatment
Recovery
11 48; M 07/2012 Flu-like symptoms
Mild hepatitis
Documented
seroconversion
None Live in the region; eat
unpasteurized goat
cheese and local
market vegetables
No treatment
Recovery
12 65; M 08/2012 Flu-like symptoms
Mild hepatitis
Documented
seroconversion
Positive PCR in
first serum while
negative serology
None Live in the region No treatment
TEE normal at screening
Recovery
13 48; M 07/2012 Flu-like symptoms
Granulomatous
hepatitis
Documented
seroconversion
None Live in the region Doxycycline 100 mg twice
daily for 10 days
TEE normal at screening
Recovery
14 40; F 08/2012 Flu-like symptoms
Hepatitis
Documented
seroconversion
Pregnancy Live in the region Doxycycline 100 mg twice
daily for 21 days
TEE normal
Recovery
MRI, magnetic resonance imaging; TA-CT, thoracoabdominal computer tomography; TEE, transoesophageal echocardiography; TNF, tumour necrosis factors; TTE, transthoracic
echocardiography.
aFollowing epidemiological investigations, discovery of patient 1 (probably the first case), who used to regularly meet friends in the index farm.
bAnnouncement to public health authorities was made when cases 1 to 5 had been identified.
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against C. burnetii using a commercial ELISA test (CHEKIT Q
fever Antibody ELISA Test Kit, IDEXX, Liebefeld, Switzerland).
For dust samples and vaginal swab examinations, DNA was
extracted using a QIAamp cador Pathogen Kit (Qiagen,
Hilden, Germany) and for manure samples with QIAamp
DNA Stool Mini Kit (Qiagen), as described by the manufac-
turer. Real-time PCR was performed using a commercial assay
(LSI Taqvet C. burnetii, Laboratoire Service International,
Lissieu, France) according to the manufacturer’s instructions.
Meanwhile, local physicians were informed about the
ongoing outbreak by an official communication. Furthermore,
the outbreak was brought to the attention of the public
through local newspapers, television and other media. Volun-
tary reporting of every new case was introduced. Based on the
literature review, particularly the experience gained from the
outbreak in the Netherlands, screening of all blood donors was
performed using a Coxiella-specific Taqman real-time PCR [24],
to limit the risk of human-to-human transmission by blood
transfusion [26].
In animals, follow-up vaginal swabs (n = 50) were taken
for PCR examinations 1 month after the initial sampling
(August 2012).These samples also included sheep that were
in contact with animals from the outbreak farm while on the
Alps, but belonging to three different owners (animal sample
sizes five, five and ten, respectively). Furthermore, two
additional dust samplings (dust sample sizes ten and five,
respectively) were carried out 1 month apart (July and
August 2012) following cleaning and disinfection of the index
farm in Lavaux.
Results
All except two patients (patients 9 and 10) lived in urban areas
and did not report direct contact with animals, except for
occasional recreational walks through the rural area of Lavaux.
All except two patients did not report ingestion of unpas-
teurized milk products. Consumption of local market products
originating from the rural area of Lavaux was common,
although the precise origin of these could not be determined.
Based on the predisposing and exposure risk factors identified
through anamnesis (Table 1), we considered that transmission
occurred by inhalation of contaminated aerosols, although
ingestion of contaminated vegetables could not be completely
excluded.
Three infected patients (patients 1, 3 and 6) regularly
visited friends on the suspected farm, where four members
of the farmer’s family showed symptoms of self-limited
febrile illness. Serology confirmed an acute infection with
C. burnetii in these patients (patients 9 and 10) whereas no
serology was performed for their two children. Taken
together, these data imply that the Q fever outbreak
originated from this farm.
This index farm housed approximately 400 meat-type sheep
(ewes with their lambs) and is located in the northern part of
Lavaux. The farmer owned an additional 750 sheep, which
were kept at different locations in the canton of Vaud. All
sheep were brought to the Alps at the end of May and grazed
together with sheep belonging to another 11 farmers, making a
total number of approximately 2000 animals. According to the
farmer, only two abortions were observed at the index farm
following shearing. All environmental samples taken at the farm
tested positive for the presence of C. burnetii DNA. Five out of
11 environmental samples (one dust and four manure samples)
were strong positives, whereas the remaining six samples (four
dust and two manure samples) tested as moderate positives.
In agreement with the farmer, veterinarians went to the
Alps and randomly sampled 52 sheep for serological and
real-time PCR examinations. Since the sheep on all locations
(i.e. farms) were grouped together, it was not possible to
specifically sample only those sheep originating from the index
farm. Nevertheless, identification of animals was possible at
‘ownership’ level. Fifteen out of 50 tested sheep (30%) tested
positive for the presence of C. burnetii antibodies. Two serum
samples with questionable results were interpreted as nega-
tive, whereas two samples could not be tested because of
insufficient amounts of blood. Real-time PCR examination of
vaginal swabs revealed 43% (22/51) of the samples to be
positive for C. burnetii DNA. For one swab no result was
obtained due to inhibition of the PCR. As for the environ-
mental samples, vaginal swab PCR results were interpreted as
weak, moderate and strong positives (qualitative result).
Table 3 shows the relationship between serological status
and vaginal shedding of 49 sheep for which both data are
available. As expected, not all seropositive animals were
TABLE 2. Frequency of some clinical features at the
moment of diagnosis among the 14 human cases documented
during the outbreak
Symptoms Frequency
% in this series
of 14 cases
Persistent fever (>14 days) 14 100
Fatigue 12 86
Liver enzyme elevation 12 86
Profuse night sweats 10 71
Inappetence 10 71
Severe headache 8 57
Myalgia 8 57
Diffuse arthralgia 6 43
Nausea 6 43
Mild weight loss 3 21
Diarrhoea 3 21
Cough 2 14
Subjective palpitations 1 7
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shedding Coxiella whereas not all shedders (i.e. PCR-positive
animals) were already seropositive at the time of investigation.
The second round of PCR examinations, which also
included sheep belonging to three additional farmers, gave 42
positive results out of 50 vaginal swabs tested. Positive samples
were found in animals owned by all four farmers. Finally, two
PCR-positive swabs were detected on each of the two
subsequent dust samplings carried out 1 month apart.
In order to avoid additional human cases, the veterinary
authorities ordered an extensive vaccination [27] of the
infected sheep flock, combined with restrictions for all sheep,
and hygiene measures on the index farm.
Following this alert, four further human cases were
reported to local authorities (patients 11 to 14) and after
these four cases, no additional cases were reported. A total of
1345 blood donors were tested negative for C. burnetii DNA
by real-time PCR in blood [24].
Discussion
This report describes an outbreak of Q fever with 14 human
cases of severe infections that occurred in the vineyard of
Lavaux, Switzerland. Diagnosis was mainly based on serology.
One case presented osteomyelitis, a rare manifestation of Q
fever, confirmed by real-time PCR. Another patient with
pre-existing valvular anomalies and a vascular aneurysm was
treated for a prolonged period for a suspected chronic Q
fever. Because of the high number and severity of cases, public
health measures were needed to mitigate the outbreak.
Precise interviews of patients about their behaviour and risk
factors were essential to identifying the possible source.
Veterinary investigations permitted the identification of a
possible reservoir, a flock of nearly 400 sheep in the northern
region of Lavaux.
A number of human Q fever outbreaks linked to sheep
farms near residential areas have already been described in
many countries [28–31]. Furthermore, 24 out of 40 outbreaks
recorded between 1947 and 1999 in Germany were associated
with sheep [32]. In Switzerland, the last reported large Q fever
outbreak in 1983 was linked to sheep descending from the
Alps, causing 415 acute Q fever cases in humans residing along
the route [21].
According to the farmer, only two abortions were observed
on the index farm and these can be attributed to stress
associated with shearing practices. However, in small rumi-
nants shedding is not always linked to abortions and bacteria
can also be shed following normal parturition [33,34]. An
association of human Q fever disease with visits to sheep farms
housing newborn lambs and without history of excess
abortions has already been described in the Netherlands
[35]. Interestingly, even a single lambing ewe has induced an
outbreak affecting hundreds of people in Germany [36]. In the
present cluster of cases, the index farm housed approximately
200 ewes and their lambs born from winter to spring 2012.
Human outbreaks of Q fever in Europe show a seasonal
pattern with peaks occurring in spring and early summer [3,37]
as was the case for this small outbreak.
In addition to birth products, infected animals also shed
bacteria with urine, milk and faeces [2–4]. In sheep, vaginal
discharge and faeces are the most common shedding routes
[38] and contribute to environmental contamination [5,6] and
to infectious aerosol spread. We have examined the presence
of C. burnetii in dust samples on surfaces inside farm housings
as well as in manure remnants on the floor. The majority of
strong positive PCR results were obtained from manure
samples. Considering that the farmer had flushed the floor
with water before sampling, these results support a massive
contamination of manure with C. burnetii. The use of sheep
manure as a fertilizer has indeed been suggested as a possible
cause of Q fever infections in humans [39]. In addition, during
the 2007–2008 outbreaks in the Netherlands, a peak incidence
of human cases has been associated with manure spreading
[40].
As all sheep were grouped together when in the Alps, it was
not possible to only sample those originating from the index
farm (n = 400). However, movements of animals and equip-
ment between the farms of the same owner are to be
expected, hence all animals belonging to the owner of the
index farm were treated as an epidemiological unit (n = 1150).
PCR-positive vaginal samples were also detected in sheep
belonging to three other farmers. Considering that farmers
usually bring their animals to the same pastures every year, the
origin of the infection cannot be proven based on these results
because it could have been introduced and spread between the
flocks already in previous years.
A positive serology only indicates past exposure and is not
proof of active infection and bacterial shedding in the
environment. The detection of shedding is of great public
TABLE 3. Comparison of molecular analysis for Coxiella
burnetii DNA from vaginal secretions and serological results
(ELISA) of 49 tested sheep, for which paired results are
available
Positive
ELISA
(n = 15)
Negative
ELISA
(n = 34)
Total
(n = 49)
Positive RT-PCR (n = 21) 7 (14%) 14 (29%) 21 (43%)
Negative RT-PCR (n = 28) 8 (16%) 20 (41%) 28 (57%)
Total (n = 49) 15 (31%) 34 (69%) 49 (100%)
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health significance and should always be included in Q fever
outbreak investigations. In this outbreak, laboratory examin-
ations revealed a large number of seropositive sheep (30%)
and an even larger number of animals shedding C. burnetii in
vaginal mucus (43%). Interestingly, only seven seropositive
animals were also shedding at the same time. This is in
accordance with previous data showing that seronegative
ruminants might shed bacteria whereas seropositive animals
do not necessarily shed [33,41]. The animals were tested
approximately 2 and 3 months following transport to the Alps,
when lambing at the farms of origin was already completed.
The positive PCR results from vaginal swabs support previous
studies showing that sheep shed for longer in vaginal
discharges than other ruminants following birthing [37].
To protect the population, all sheep were vaccinated,
hygiene measures were applied at the index farm and
movement restrictions were imposed to all sheep on the
Alps. The persistence of PCR-positive dust samples following
disinfection is attributed to the old premises of the farm that
could not be effectively cleaned and disinfected. Testing all
blood donors did not reveal any positive test, and we do not
advise repeating this measure as routine, although in a large Q
fever outbreak, such PCR testing could avoid human-to-human
transmission by transfusion.
This cluster of cases permitted the improvement of both
public and physician awareness of Q fever and helped
consideration of this illness as a prolonged febrile illness.
Indeed, its recognition is important for timely diagnosis and to
avoid long-term consequences. Furthermore, this outbreak
highlights the risk of Q fever transmission from animals to
humans in residential areas located near farms. Considering
the ongoing urbanization, strong cooperation of public health
and infectious diseases specialists and veterinary scientists is
crucial for the prevention and control of future Q fever
outbreaks.
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